Biosurgery Companies
Biosurgery involves the use of biological materials, such as tissues, blood components, or biomaterials, to aid in the surgical healing process. This can include products used in hemostasis, tissue sealing, and wound management.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Latest Biosurgery Companies Updates:
Johnson & Johnson (Ethicon): Launched the Tissuelok™ Fibrin Sealant Plus Spray in October 2023, offering faster application and improved visibility for surgeons during tissue sealing procedures.
Stryker Corporation: Received FDA approval for the QuikClot™ Absorbable Hemostatic Sponge in November 2023, providing a bioabsorbable option for controlling bleeding during surgery.
Integra Lifesciences Corporation: Collaborated with a leading research institute in December 2023 to develop 3D-printed bone grafts for personalized reconstruction procedures.
Baxter International: Partnered with a startup company in January 2024 to commercialize a novel hydrogel sealant for wound closure, expanding their biosurgery product portfolio.
Medtronic plc: Announced the expansion of its regenerative medicine program in February 2024, aiming to invest in and develop innovative tissue engineering solutions for various medical conditions.
List of Biosurgery Key companies in the market:
- Baxter International, Inc.
- Braun Melsungen AG
- R. Bard
- Johnson & Johnson
- Medtronic, PLC.
- MAQUET Holding B.V. & Co. Kg. (Getinge Group)
- Cohera Medical Inc.
- Integra Lifesciences Holdings Corporation
- Commonwealth Serum Laboratories (CSL)
- Hemostasis, LLC
- Sanofi
- Pfizer Inc.
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
